Lanreotide Subcutaneous and Polycitra-LC
Determining the interaction of Lanreotide Subcutaneous and Polycitra-LC and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
Generic Name: citric acid / potassium citrate / sodium citrate
Brand name: Cytra-3, Polycitra, Polycitra-LC, Tricitrates, Virtrate-3
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lanreotide Subcutaneous-Polyethylene Glycol 3350 NF PEGYLAX
- Lanreotide Subcutaneous-Polyethylene Glycol
- Lanreotide Subcutaneous-Polyethylene glycol 3350
- Lanreotide Subcutaneous-Polyethylene glycol 3350 and electrolytes
- Lanreotide Subcutaneous-Polyethylene glycol 3350, electrolytes, and ascorbic acid
- Lanreotide Subcutaneous-Polyethylene glycol 3350, sodium and potassium salts
- Polycitra-LC-Lansoprazole
- Polycitra-LC-Lansoprazole Delayed-Release Capsules
- Polycitra-LC-Lansoprazole Orally Disintegrating Tablets
- Polycitra-LC-Lansoprazole, Amoxicillin, and Clarithromycin
- Polycitra-LC-Lanthanum
- Polycitra-LC-Lanthanum carbonate